Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chapman Molony was a specialized firm of UK and European patent and trademark attorneys that provided intellectual property services to the life sciences, engineering, and technology sectors. Founded in 2003 by Anna Molony and Helga Chapman, the firm established a reputation for its expertise in patent drafting, prosecution, and IP strategy, serving a diverse client base ranging from startups to multinational corporations. The firm eventually rebranded as Chapman IP and was acquired by the global IP firm Murgitroyd & Co in February 2019 for approximately £6.6 million. Following the acquisition, the firm's operations were integrated into Murgitroyd's network, strengthening its presence in the UK's southern technology corridors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chapman Molony.